{
  "id": 1503475,
  "title": "Biotech's reverse merger renaissance poised to continue",
  "url": "https://urgent.news/2026/08/17/biotechs-reverse-merger-renaissance-poised-to-continue",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-17T15:12:10.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/biotechs-reverse-merger-renaissance-poised-to-continue/"
  },
  "original_language": "en",
  "account": null,
  "summary": "A biotech collected $820 million in investor commitments this month to take its China-sourced immunology drug onto the public markets. That would make it one of the largest, if not the ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}